MedTrace Logo

Observational Study to Evaluate Short and Long-term Safety of the ABSORB Scaffold

NCT02066623 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3330

Last updated 2022-04-01

No results posted yet for this study

Summary

The German-Austrian ABSORB Register shall provide an analysis of acute and long-term safety as well as therapy outcomes of the ABSORB (trade mark) bioresorbable vascular scaffold system in patients suffering from coronary artery disease.

Conditions

  • Coronary Artery Stenosis

Interventions

DEVICE

ABSORB Scaffold

Implantation of a drug-eluting vascular scaffold, which is completely resorbable to improve the blood flow in coronary arteries in the presence of stenosis

Sponsors & Collaborators

  • Abbott Medical Devices

    collaborator INDUSTRY

  • IHF GmbH - Institut für Herzinfarktforschung

    lead OTHER

Principal Investigators

  • Christian Hamm, Prof. Dr. · University Clinic Giessen and Kerckhoff-Clinic Bad Nauheim

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-08
Primary Completion
2016-01-31
Completion
2021-07-06

Countries

  • Austria
  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02066623 on ClinicalTrials.gov